Author

W. Goodman

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:database / resource· 1 Research Focus:drug response / drug discovery· 1 Assay:electrophysiology· 1 Organism:mouse· 1

Frequent Co-Authors

A. Desai· 1 shared A. Dhuliyawalla· 1 shared A. K. Wakhloo· 1 shared A. Lauko· 1 shared A. Robledo· 1 shared A. Valujskikh· 1 shared C. Li· 1 shared D. Bayik· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Desai

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Endocisternal interfaces for minimally invasive neural stimulation and recording of the brain and spinal cord

J. C. Chen, A. Dhuliyawalla, R. Garcia, A. Robledo, J. E. Woods, F. Alrashdan, S. O'Leary, S. Crosby, M. M. Felicella, A. K. Wakhloo, P. Karas, W. Goodman, S. A. Sheth, S. A. Sheth, J. Robinson, P. Kan

This paper introduces a chronic endocisternal neural interface for minimally invasive brain and spinal cord stimulation and recording, demonstrating repositioning and explantation capabilities in a large animal model.

bioRxiv · Oct 12, 2023Bioengineering

Sex-specific T cell exhaustion drives differential immune responses in glioblastoma

J. Lee, M. Nicosia, D. J. Silver, C. Li, D. Bayik, D. C. Watson, A. Lauko, S. Johnson, M. McGraw, M. Grabowski, D. Kish, A. Desai, W. Goodman, S. Cameron, H. Okada, , J. D. Lathia

This study shows male T cells are more exhausted in glioblastoma, leading to worse outcomes and better response to anti-PD1 treatment compared to females.

bioRxiv · Aug 17, 2022 · PreprintImmunology